Liver Cancer

Who might be able to join this trial: - People who are scheduled to have, or have already had, imaging or treatment on a machine called an MR-Linac (a combined MRI scanner and radiation therapy machine) - People who are willing and able to sign a written consent form agreeing to take part - People who are 18 years of a...

**Who might be able to join this trial:** - You have been diagnosed with cirrhosis (scarring of the liver) from any common cause, AND your liver is difficult to see clearly on an ultrasound scan. - Your cirrhosis has been confirmed in at least one of these ways: through a liver biopsy, through past serious liver compl...

**Who might be able to join this trial:** - People who have colorectal cancer that has spread to the liver (liver metastases) that cannot currently be fully removed by surgery, or may only potentially be removable, and where the remaining healthy liver after surgery would be too small (less than 30%, or less than 40%...

**Who might be able to join this trial:** - People who are 18 years of age or older and considered a legal adult in their country at the time they enter the study - People who have been confirmed by their treating doctor to have a primary liver or bile duct cancer (specifically, unresectable hepatocellular carcinoma o...

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed (confirmed by tissue sample) with advanced, recurrent, metastatic, or inoperable liver cancer (HCC) — or, for one part of the trial, possibly other tumour types that express a protein called GPC3 (confirm with tr...

**Who might be able to join this trial:** - You have liver cancer (HCC) that has spread to other parts of the body, cannot be surgically removed, or is at an advanced stage - You are in generally good physical condition and able to carry out daily activities with little or no restriction (confirmed by a doctor's asses...

**Who might be able to join this trial:** - People who are 18 years of age or older. - People who are generally well enough to carry out light activity or desk work (a doctor would assess this using a standard scale). - People who are willing to allow the trial team to access stored tumour tissue, past scan results, a...

Who might be able to join this trial: - People who have been diagnosed with locally advanced or inoperable liver cancer (hepatocellular carcinoma), confirmed through a tissue biopsy or sample. - People whose general health and ability to carry out daily activities meets a specific standard, rated 0 or 1 on a medical sc...

Who might be able to join this trial: - You are in good general health and able to carry out daily activities with little or no difficulty (as measured by a standard health scale called ECOG, scored 0 or 1). - You are expected to live for at least 12 weeks from the time of joining the trial. - Your heart, liver, kidney...

Who might be able to join this trial: - People who have been diagnosed with a single, new liver cancer (hepatocellular carcinoma) measuring 8 cm or smaller, confirmed by tissue sample or imaging scan, at an early stage (BCLC stage 0 or A). - People with a previous liver cancer diagnosis may still be considered, provide...

**Who might be able to join this trial:** - You have been diagnosed with a type of colorectal cancer called adenocarcinoma (a cancer that started in the colon or rectum). - Your cancer had spread (Stage IV), but only to the liver — not to other parts of the body. - You have had surgery with the goal of fully removing...

Who might be able to join this trial: - People who have a suspected or known diagnosis of neuroblastoma, osteosarcoma, Ewing sarcoma, or soft tissue sarcoma, with a tumour that can be surgically removed — tissue, bone marrow, or blood samples may be collected at different points such as biopsy, surgery, or if the cance...

**Who might be able to join this trial:** - People who receive ongoing outpatient care at the University of Chicago Medical Center under a doctor who is participating in this trial - People who are 18 years of age or older - People with a life expectancy of at least 3 years - People who are currently taking between 1 a...

**Who might be able to join this trial:** - You have been diagnosed with bowel cancer (colon or rectal cancer) that has been confirmed by a tissue sample (biopsy). - Scans (PET/CT and CT or MRI of the chest, abdomen, and pelvis) show the cancer has not spread outside the liver, and there is no sign of the original can...

Who might be able to join this trial: - People who have been diagnosed with colorectal cancer, either in its original location or that has spread to the liver, where the treatment plan includes surgery with the goal of curing the condition - People aged 18 or older - People who have agreed to take part and provided wri...

**Who might be able to join this trial:** - People who have been diagnosed with colon cancer (confirmed by tissue testing) that has not spread to distant parts of the body (stage I, II, or III), and who are planning to have surgery to remove the tumor. - People who have been diagnosed with colon cancer (confirmed by t...

**Who might be able to join this trial:** - People who have a well-differentiated neuroendocrine tumour (NET) that has spread to the liver, where the liver is the main site of disease, regardless of where the original tumour started or whether the tumour is producing hormones. - People whose liver tumours, while any s...

**Who might be able to join this trial:** - People who have a performance score (a measure of general health and ability to carry out daily activities) of 70 or above on the Karnofsky Performance Scale, indicating they are reasonably functional - People who have between 1 and 4 tumours that have spread to the liver, w...

**Who might be able to join this trial:** - People who have been diagnosed with colorectal cancer (cancer of the colon or rectum) confirmed by a tissue biopsy. - People whose cancer has spread to the liver in a way that cannot be removed by surgery. - People whose scans (PET/CT) taken within 4 weeks before the transpl...

Who might be able to join this trial: - People who have a high-risk primary colorectal cancer (a new cancer in the colon or rectum that has not been treated before). - People whose CT scan shows no signs of cancer that has spread to the liver. - People who would be able to receive treatment if cancer in the liver were...

**Who might be able to join this trial:** - The person must live in Canada. - The person must be in generally good physical condition and able to carry out daily activities, as measured by a standard health scoring system called the ECOG scale (scores 0–1, with brief dips to score 2 allowed at the doctor's discretion)...

**Who might be able to join this trial:** - You have been diagnosed with colorectal cancer (bowel cancer) that has spread to the liver, confirmed by a tissue sample (biopsy) - You have at least one liver tumour that can be measured using standard scanning methods - Your cancer has only spread to the liver, or if it ha...

Who might be able to join this trial: - People who have at least one liver tumour that has been confirmed by laboratory tissue testing to be a type of cancer called adenocarcinoma that has spread (metastasised) to the liver. - People who have been confirmed by laboratory tissue testing to have adenocarcinoma of the col...

Who might be able to join this trial: - People aged 75 or younger with colorectal cancer (bowel cancer) that has been confirmed by a laboratory test on a tissue sample - People whose major organs (such as the heart, lungs, kidneys, and liver) are functioning without severe problems - People with a WHO performance statu...

Who might be able to join this trial: - People who have gallbladder cancer that has reached a certain stage (called T2 or T3), as seen on a CT scan before surgery - People who have been confirmed by laboratory testing (looking at tissue samples) to have T2 or T3 gallbladder cancer after having their gallbladder removed...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma), either confirmed by a tissue sample or by medical imaging - People who have 1 to 3 liver tumours that are suitable for a type of targeted radiation treatment called stereotactic body radiation therapy (S...

Who might be able to join this trial: - Adults aged between 18 and 70 years who have been diagnosed with a specific type of bowel cancer (adenocarcinoma or poorly differentiated carcinoma of the colon or rectum) that has spread to the liver only, cannot be removed by surgery, and has not spread to any other part of the...

**Who might be able to join this trial:** - People who have been confirmed by laboratory testing to have a type of bowel cancer (adenocarcinoma) that started in the colon or rectum. - People whose cancer has spread to the liver, but where surgery to remove the liver tumours is not possible. - People who have no signs...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma) that cannot be removed by surgery. - People who are able to understand the study information and sign a written consent form agreeing to take part, following the rules of the institution running the trial...

Who might be able to join this trial: - People who are already scheduled to receive Y90 radioembolization therapy using SIR-Spheres or TheraSpheres (a type of internal radiation treatment) - People who are able to stay at the hospital for extra PET/CT scans (a type of medical imaging) after their treatment - People who...

Who might be able to join this trial: - Adults aged 18 or older, of any gender, with no upper age limit. - People rated as relatively healthy to moderately unwell under a standard pre-surgery health classification system (ASA physical status I to III). - People scheduled for planned (non-emergency) open abdominal liver...

**Who might be able to join this trial:** - People diagnosed with hepatocellular carcinoma (liver cancer) that cannot be removed by surgery, classified as intermediate-stage (BCLC stage B, or Child-Pugh class A or B with large or multiple tumours, and no spread to blood vessels or outside the liver), who have complete...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by a tissue sample or imaging scan such as a CT or MRI. - People aged 18 years or older. - People whose liver cancer is at an advanced stage and cannot be surgically removed, as determ...

**Who might be able to join this trial:** - People who have been diagnosed with a primary liver or bile duct cancer confirmed by a tissue test (biopsy or pathology report). - People who have cancer that has spread to the liver (from a non-lymphoma cancer), confirmed by a tissue test. - People whose liver lesions appea...

**Who might be able to join this trial:** - Adults aged 18 or older - People who are generally well enough to carry out daily activities with little or no limitation (as measured by a standard health scale called ECOG, score 0 or 1) - People who have been diagnosed with liver cancer (HCC) through a tissue sample, wher...

**Who might be able to join this trial:** - People who test positive for hepatitis B surface antigen (HBsAg) with levels at or above a certain threshold in their blood - People who are 18 years of age or older at the time of signing consent - People who are able to understand and follow the study requirements, and who...

Who might be able to join this trial: - People aged 18 years or older. - People with liver cancer (hepatocellular carcinoma, or HCC) confirmed by tissue testing and/or medical imaging (this applies to Group 2 of the study). - People with a type of bile duct cancer found inside the liver (intrahepatic cholangiocarcinoma...

Who might be able to join this trial: - You were treated (or are currently being treated) for a liver tumor as a child or young person under the age of 21, whether the tumor was cancerous or non-cancerous. - You are a biological (blood-related) parent or biological sibling of a child who meets the above criteria. Who...

**Who might be able to join this trial:** - People who have been diagnosed with cancer that has spread (metastasised) to the liver from another part of the body - People whose cancer is either confined to the liver, or has spread only to a limited number of sites outside the liver that have been stable or controlled fo...

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by tissue or cell testing - People whose liver cancer has been classified at a mid-to-advanced stage (BCLC stage B or C) - People with a...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) that has come back, confirmed by a tissue or cell test. - People who previously had a liver transplant as a curative treatment for their liver cancer. - People whose returned cancer cannot...

**Who might be able to join this trial:** - You have been diagnosed with a specific type of slow-growing tumour called a neuroendocrine tumour (grade 2 or 3) that has spread to the liver and cannot be removed by surgery - You have at least one tumour in the liver that is larger than 1 cm in size - Most of your tumour...

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been receiving care in a Nephrology (kidney) department since 2015 - People with cholangiocarcinoma (a type of cancer affecting the bile ducts) that has been confirmed through tissue or cell testing, at any stage of the disease...

**Who might be able to join this trial:** - People who have been newly diagnosed with hepatocellular carcinoma (a type of liver cancer) - People with a suspected case of this type of liver cancer, regardless of the cause, stage, or treatment involved - People with a known diagnosis of this liver cancer who are receivin...

**Who might be able to join this trial:** - Adults over 18 years old, of any gender - People without liver scarring (cirrhosis) who have had liver cancer confirmed by a tissue biopsy within the past month before surgery, OR people with liver scarring whose liver cancer has been identified using a specialised MRI or CT...

**Who might be able to join this trial:** - The patient (or their legal guardian, for those under 18) must be willing and able to give written consent to participate, and must be able to understand the study and its risks — including patients with a history of major psychiatric illness, as assessed by the trial team....

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC), either confirmed by a tissue biopsy or meeting specific imaging and blood test criteria set by a leading liver disease organisation (AASLD) - People whose liver function falls into a categor...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC) — either confirmed by tissue sample, or in some cases by imaging scans that meet specific medical guidelines — and whose cancer has continued to grow during or after treatment with certain im...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on tissue testing or imaging scans - People who have at least one liver tumour that can be treated with a procedure called TACE (a targeted treatment delivered directly to the tumour throu...

**Who might be able to join this trial:** - You have been diagnosed with colorectal cancer that has spread (metastasized) to the liver, and the liver is the main area affected. - Your liver metastasis has been confirmed either through a tissue/cell sample (biopsy) or through scans and clinical assessment. - Your liver...

Who might be able to join this trial: - You have been diagnosed with liver cancer (hepatocellular carcinoma) that is linked to liver scarring (cirrhosis) - You are between 18 and 70 years old - The total size of all your tumours combined is less than 500 cm³ (confirm with trial site) - You have fewer than 10 separate t...

**Who might be able to join this trial:** - A surgeon, radiologist, or oncologist has diagnosed the person with primary hepatocellular carcinoma (liver cancer) following international guidelines, or the diagnosis has been confirmed by a tissue sample (biopsy) - The person is either unable to have other treatments or h...

**Who might be able to join this trial:** - A surgeon, radiologist, or oncologist has diagnosed the person with primary liver cancer (hepatocellular carcinoma, or HCC), either through imaging or a tissue sample, following international guidelines - The person has a single liver tumour that measures between 5 and 10 cm...

**Who might be able to join this trial:** - You have been confirmed through a tissue biopsy to have a specific type of liver cancer called intrahepatic cholangiocarcinoma (iCCA) - This is either your first time being diagnosed with iCCA, or the cancer has come back only in the liver after a previous liver surgery - Do...

**Who might be able to join this trial:** - People who have been diagnosed with a type of liver cancer called hepatocellular carcinoma, confirmed either by a tissue sample (biopsy) or by meeting recognised medical imaging guidelines - People whose cancer appears as a single tumour measuring between 3 and 8 centimetres...

Who might be able to join this trial: - Adults aged 18 or older - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), either confirmed by a tissue sample (biopsy) or by MRI or CT scan showing typical signs of liver cancer alongside liver cirrhosis - People whose liver cancer is classi...

**Who might be able to join this trial:** - People aged 18 or older (confirm upper age limit with trial site, as it appears incomplete in the source criteria) - People with a good general health and activity level, as measured by a standard medical scale called ECOG, scoring 0 or 1 (meaning fully active or able to carr...

**Who might be able to join this trial:** - You have been diagnosed with an advanced or spreading solid tumor cancer that has been confirmed by a tissue sample (biopsy). - You are generally able to care for yourself and carry out daily activities, even if you cannot do heavy physical work (based on a standard doctor's...

**Who might be able to join this trial:** - People who have been diagnosed with hepatoblastoma (HB), hepatocellular neoplasm not otherwise specified (HCN-NOS), or hepatocellular carcinoma (HCC), confirmed by a tissue sample, with a specific protein marker (AFP) above 100 ng/mL in their blood at the time of screening....

**Who might be able to join this trial:** **For people with lung or liver cancer:** - People aged 21 or older - People who have a primary or secondary (spread-from-elsewhere) tumour located in the lungs or liver - People whose tumour(s) measure less than 7 cm across - People whose treating radiation specialist has alr...

**Who might be able to join this trial:** - People who have been diagnosed with a cancer linked to the Epstein-Barr virus (EBV), such as nasopharyngeal cancer (a type of cancer in the back of the nose and throat). - People who have been diagnosed with a cancer linked to the human papillomavirus (HPV), including certai...

**Who might be able to join this trial:** - People diagnosed with colorectal cancer that has a specific gene change called a RAS mutation (either KRAS or NRAS) - People whose colorectal cancer has spread to the liver (one or more spots) - People for whom surgeons have planned a complete surgical removal of the liver tu...

**Who might be able to join this trial:** - The person's primary cancer has been confirmed by tissue testing as colorectal adenocarcinoma (a type of bowel cancer). - Liver metastases (cancer that has spread to the liver) have been assessed by a specialist medical team as not suitable for surgery at this stage. - Speci...

**Who might be able to join this trial:** - People who have been diagnosed with a primary liver or bile duct cancer confirmed by a pathology test, OR liver tumours that have spread from another cancer (not lymphoma) confirmed by pathology, OR liver tumours that look like spread cancer on scans in someone already known...

Who might be able to join this trial: - People who have been diagnosed with a solid advanced malignant (cancerous) tumour - People who are between 18 and 99 years of age - People whose doctors estimate they have a life expectancy of more than three months Who may not be able to join: - People who have a benign (non-ca...

**Who might be able to join this trial:** - People aged between 18 and 75 years - People diagnosed with early-stage liver cancer (BCLC Stage A) that has a high risk of coming back after treatment - People whose liver cancer can be removed through surgery - People whose liver is functioning at a level classified as Chil...

Who might be able to join this trial: - People with colorectal cancer that has spread to the liver and who are scheduled to have surgery to remove those liver tumours. - People who have at least one liver tumour that is 3cm or larger in size. - People who are in generally good physical health, able to carry out daily a...

Who might be able to join this trial: - People aged between 18 and 85 years old - People who have an advanced solid tumor (a type of cancer) that has come back or has not responded to previous treatment - People whose doctors estimate they are likely to live for more than three months Who may not be able to join: - Pe...

**Who might be able to join this trial:** - Adults aged 18 or older who have signed a consent form to participate - People with a confirmed diagnosis of hepatocellular carcinoma (a type of liver cancer), confirmed by tissue sample or specific imaging scans - People whose liver cancer is at an intermediate stage — mean...

**Who might be able to join this trial:** - People diagnosed with advanced primary liver cancer (specifically hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or a combined type) where standard treatments have stopped working, were not tolerated, or no standard treatment exists. Note: in the second part of t...

**Who might be able to join this trial:** - Adults aged 18 or older. - People who are able to understand, sign, and date a consent form before any trial procedures begin. - People who are willing and able to follow the study schedule, attend visits, and provide the required samples as set out in the trial plan. - Peop...

**Who might be able to join this trial:** - You have advanced cancer that has not responded to currently available treatments - Doctors expect you to live for more than 12 weeks - Your heart, lungs, liver, and kidneys are all working well enough (confirm with trial site) - A tissue sample (biopsy) or fluid sample from...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC) that cannot be surgically removed, has come back, or has spread to other parts of the body — confirmed by a tissue biopsy. - People whose liver cancer tumors test positive for a protein calle...

**Who might be able to join this trial:** - People who have been diagnosed with a malignant (cancerous) liver tumour and are being considered for a specific major liver surgery that removes a large portion of the liver - People who have given their consent to take part - People aged 18 or older - People whose remainin...

**Who might be able to join this trial:** - Adults between 18 and 75 years old (exact age range may vary depending on local rules). - For the dose-finding phase of the trial: people with advanced solid tumours (confirmed by tissue or cell testing) that have grown or spread despite standard treatment, or where no stand...

**Who might be able to join this trial:** **For people with liver cancer (hepatocellular carcinoma / HCC):** - People who have been newly diagnosed with liver cancer, or whose liver cancer has come back, confirmed by a biopsy or by standard medical imaging criteria, where surgery (with or without ablation) is planned...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (liver cancer) either through a tissue biopsy or through a CT or MRI scan using a specific liver imaging assessment system - People who are 18 years of age or older - People whose general physical functioning falls...

Who might be able to join this trial: - You are willing and able to agree to take part in the study by giving your consent. - You are male or female, aged between 18 and 75 years old. - *(Malignancy group only)* You have been diagnosed with, or doctors suspect you may have, a cancer affecting the liver or bile ducts. -...

Who might be able to join this trial: - People who have a solid advanced cancer (a tumour that has spread or cannot be removed) - People who are between 18 and 80 years old - People who are expected to live for more than three months Who may not be able to join: - People who have a non-cancerous (benign) tumour - Peop...

**Who might be able to join this trial:** - People aged 18 or older (there is no upper age limit) - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed either by tissue sample or by imaging scans, following specific cancer network guidelines - People whose cancer cannot be t...

Who might be able to join this trial: - You are having planned surgery to remove part of your liver because of cancer (either a cancer that started in the liver or one that spread there from elsewhere) - Your surgery is scheduled in advance and is not an emergency - You are 18 years of age or older - Your surgeon plans...

**Who might be able to join this trial:** - People who are able to give written agreement to participate, including following all study rules and procedures - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC) that cannot be surgically removed, confirmed either by tissue sample or by s...

**Who might be able to join this trial:** - Imaging results strongly suggest a type of bile duct cancer called perihilar cholangiocarcinoma (pCCA) (confirm with trial site) - The cancer may involve certain blood vessels near the liver, but must not have blocked the main portal vein outside the liver - The cancer may i...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), confirmed either through a tissue sample or medical imaging - People aged between 18 and 80 years old - People who have between 1 and 3 liver tumours - People whose tumour is at least 4 cm in s...

**Who might be able to join this trial:** - Adults aged 18 or older at the time of joining the study. - People who have signed a written consent form agreeing to take part. - People who have been diagnosed with liver cancer (hepatocellular carcinoma) or bile duct cancer originating in the liver (intrahepatic cholangio...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer, stones in the liver's bile ducts (hepatolithiasis), or a non-cancerous liver tumour, and whose doctors have determined that surgery to remove part of the liver is the right treatment - People whose liver is functioning at a l...

**Who might be able to join this trial:** - You have cancer that has spread (metastasized) to the lung, liver, or soft tissue from any original cancer type, and it cannot be cured with local treatments alone. - You may have had one previous treatment with a type of immunotherapy called anti-PD-1/L1 therapy. - You have...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma) - People who are planned to have surgery to remove part of the liver (hepatectomy) - People whose liver is functioning at a level classified as Child-Pugh A or B (a measure of liver health — confirm w...

**Who might be able to join this trial:** - People who have signed a written consent form agreeing to participate in the study. - People who are 18 years of age or older at the time of joining the study. - People who have been diagnosed with liver cancer (hepatocellular carcinoma) that cannot be surgically removed or...

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with stage IV colon or rectal cancer that has spread to the liver only, and your doctors are planning surgery to remove part of your liver with the goal of curing you - Instead of, or in addition to liver surgery, yo...

Who might be able to join this trial: - Adults between the ages of 19 and 79 years old - People who have signed a consent form agreeing to take part in the trial - People diagnosed with liver cancer (hepatocellular carcinoma) confirmed by MRI, contrast-enhanced CT scan showing a liver lesion larger than 1 cm, or by tis...

Who might be able to join this trial: - You must be 18 years old or older - You must have been attending a liver screening program for at least 6 months at a specialist liver centre - You must have cirrhosis (scarring of the liver) confirmed either by a biopsy or by other accepted medical tests - A recent scan (within...

**Who might be able to join this trial:** - People aged 18 or older at the time of joining the study. - People who have liver metastases (cancer that has spread to the liver from another part of the body) that cannot be removed by surgery. - People whose cancer continued to grow or stopped responding to at least one p...

Who might be able to join this trial: - Doctors who have completed their radiology residency training (not currently in training) - Radiologists who have specialized training in imaging of the abdomen, either currently undergoing or already completed - Radiologists who have experience reading liver scans, regardless of...

**Who might be able to join this trial:** - People who have given written consent to take part before treatment begins, including consent to radiation and medication - People aged 18 to 70 years old, of any gender - People who have been newly diagnosed with small cell lung cancer (SCLC), confirmed by a tissue or cell s...

**Who might be able to join this trial:** - People aged 18 or older who have been diagnosed with liver cancer (hepatocellular carcinoma), confirmed either by a tissue sample or through established clinical guidelines. - People whose liver cancer is advanced, has spread to other parts of the body, or cannot be surgical...

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with cancer, are in cancer remission, have a benign (non-cancerous) condition such as a benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or C, or chronic obstructive pulmonary disease, or people...

**Who might be able to join this trial:** - Your original colorectal (colon or rectal) cancer tumor was fully removed with surgery, leaving no cancer cells at the edges of the removed tissue - You have cancer that has spread to the liver that cannot be removed with surgery, either from the start or after previous live...

**Who might be able to join this trial:** - Adults aged 18 or older at the time of signing the consent form - People who have liver cancer (hepatocellular carcinoma, or HCC) that cannot be surgically removed and has spread beyond what is considered the Milan criteria (a set of size and number limits used in transplant...

**Who might be able to join this trial:** - People who have been diagnosed with a specific type of liver cancer called Hepatocellular Carcinoma (HCC) — confirmed by imaging, tissue sample, or cell sample — and whose cancer is considered suitable for surgical removal (note: certain subtypes called fibrolamellar and mix...

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with colon or rectal cancer (inside the abdominal cavity) confirmed by a tissue sample (biopsy) - Your original tumor meets specific pathology requirements: it was at an early-to-moderate stage, was fully removed with...

**Who might be able to join this trial:** - People who have colorectal cancer that has spread to the liver, where the tumour is on the borderline of being removable by surgery, or currently cannot be safely removed because there is not enough healthy liver remaining — and where the surgical team believes surgery with...

**Who might be able to join this trial:** - Adults aged 18 or older, of any sex. - People who have cirrhosis, or who meet the medical guidelines for regular liver cancer (HCC) monitoring. - People who have been clinically diagnosed with liver cancer (HCC), or people who have been checked and found not to have liver ca...

**Who might be able to join this trial:** - Adults aged 18 or older of any sex - People who have been diagnosed with hepatocellular carcinoma (liver cancer), confirmed either by tissue biopsy (for those without liver scarring/cirrhosis) or by a recognised specialist guideline process (for those with cirrhosis) - Peopl...

Who might be able to join this trial: - Adults who are over 18 years of age - People who have been diagnosed with suspected rectal cancer (either through a camera examination of the bowel or based on clinical assessment) and are being considered for further imaging tests - People who are able to understand the trial in...

**Who might be able to join this trial:** - People who are able and willing to give written consent to participate. - Adults aged 18 or older, of any sex. - People who are relatively well and able to carry out daily activities, based on a standard cancer performance scale (ECOG score of 0 or 1). - People in Cohort 2:...

**Who might be able to join this trial:** - People aged 18 to 75 years old, of any gender - People who have been diagnosed with colorectal cancer that has spread to the liver, had surgery to remove the original colorectal cancer, and had complete surgical removal of the liver spread (and any other organ involvement),...

**Who might be able to join this trial:** - People aged 18 or older (20 or older for participants in Taiwan) - People who have been diagnosed with liver cancer (hepatocellular carcinoma), confirmed by a tissue sample, cell sample, or by specific imaging scans showing a liver tumour of 1 cm or larger - People whose liv...

Who might be able to join this trial: - People aged 18 to 89 years old - People diagnosed with liver cancer (called hepatocellular carcinoma, or HCC) that developed alongside a chronic liver condition or scarring of the liver (cirrhosis), regardless of the underlying cause, diagnosed according to specific French medica...

**Who might be able to join this trial:** - Adults aged over 18 years old - People whose general health and ability to carry out daily activities meets a certain standard (a medical scoring system called ECOG gives a score of less than 2, meaning the person is reasonably active — confirm with trial site) - People who h...

Who might be able to join this trial: - You have cirrhosis (scarring of the liver) from any cause, or you have a long-term hepatitis B infection - You are considered at high risk of developing liver cancer (hepatocellular carcinoma) - You are between 18 and 75 years old - You are able to understand and agree to partici...

**Who might be able to join this trial:** **As a blood donor (providing blood for the treatment):** - People who are able to understand and sign the consent forms, knowing this is an experimental study - People aged 20 years or older - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC)...

Who might be able to join this trial: - Adults aged 18 or older, of any gender - People who have been diagnosed with colorectal cancer, confirmed by a tissue biopsy - People whose previous scans showed spots on the liver that may be cancer that has spread there - People who are willing and able to follow the study proc...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma/HCC), confirmed by imaging or tissue testing. - People who have already received at least one whole-body (systemic) treatment for liver cancer — or, for those with a specific liver function score (Chi...

Who might be able to join this trial: - People who are 20 years of age or older and living in one of the 16 selected villages in Khon Kaen province, Thailand Who may not be able to join: - People who are 19 years old or younger - People who do not live in one of the 16 pre-selected villages in Khon Kaen province, Thai...

Who might be able to join this trial: - People between 20 and 80 years old. - People rated as ASA physical status class I, II, or III, meaning their overall health falls within a range accepted by the trial (confirm with trial site). - People who are having part of their liver surgically removed to treat liver cancer (...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) - People who are 18 years of age or older Who may not be able to join: - People who do not wish to take part in the study - People whom the responsible investigator determines are not suitable...

**Who might be able to join this trial:** - People who have given written consent to take part in the study - People whose primary diagnosis is liver cancer (HCC), who are planned to receive radiation treatment, have not yet received any systemic (whole-body) drug treatment for liver cancer, and may have previously ha...

Who might be able to join this trial: - You must be 18 years of age or older - You have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by a special type of CT scan or MRI scan showing specific patterns of blood flow in the liver - You have been diagnosed with liver cancer confirmed by a tissue bi...

**Who might be able to join this trial:** - People who have been clearly diagnosed with hepatocellular carcinoma (a type of liver cancer) that is large or advanced within the liver, but has not spread outside the liver, and meets specific size or blood vessel involvement criteria as assessed by both the local site and...

Who might be able to join this trial: - People who are willing and able to sign a written consent form agreeing to take part in the study. - People aged between 18 and 70 years old at the time of joining the study. - People who are generally well or have only mild limitations in daily activity, as measured by a standar...

**Who might be able to join this trial:** - People aged 18 to 75 years old, of any gender - People diagnosed with hepatocellular carcinoma (a type of liver cancer) either through standard clinical guidelines or confirmed by tissue or cell testing, with at least one tumour that is large enough to be measured on a scan...

**Who might be able to join this trial:** - People who have chosen to take part voluntarily and have signed a consent form - Adults aged 18 to 75, of any gender - People whose general physical functioning is rated at a mild-to-moderate level (ECOG score 0–2; confirm with trial site if unsure what this means) - People...

Who might be able to join this trial: - People who are at least 18 years old and are willing to give formal consent to take part in the study - People who have been diagnosed with liver cirrhosis (scarring of the liver) for any reason, based on clinical assessment, imaging, or tissue testing before surgery - People who...

**Who might be able to join this trial:** - People who are able to understand the study and are willing to give their consent and follow the study rules and procedures. - People who are 18 years of age or older at the time of giving consent. - People who have been diagnosed with liver cancer (HCC) that has spread or c...

**Who might be able to join this trial:** - People who are able to understand and sign a written consent form - People who are older than 18 years of age - People who have been confirmed through a tissue test (biopsy) to have liver cancer (HCC) that can be surgically removed and is at an early or intermediate stage -...

**Who might be able to join this trial:** - Adults aged 18 years or older - People with an advanced digestive cancer that has been confirmed by a tissue sample or scan, including certain types such as gastrointestinal stromal tumour (GIST), bowel cancer that has spread (mCRC), liver cancer (HCC), or certain types of p...

**Who might be able to join this trial:** - People diagnosed with primary liver cancer (hepatocellular carcinoma, or HCC) that is at an early to intermediate stage (classified as BCLC 0 to B), confirmed by pathology results. - People whose liver cancer has come back (recurred) and who have not yet received any cancer-...

**Who might be able to join this trial:** - People who are willing and able to give written consent, and who can attend scheduled visits, follow the treatment plan, and complete required tests. - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by tissue, cell, or imaging...

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People whose general health and ability to carry out daily activities meets a minimum standard (known as a KPS score of 70 or above — confirm with trial site if unsure what this means) - People who have been diagnosed with hepatocellu...

**Who might be able to join this trial:** - People aged between 18 and 65 years old - People who have been diagnosed with a long-term hepatitis B infection, confirmed by positive blood test results for more than 6 months - People who have been diagnosed with liver cancer and have been treated with immune checkpoint in...

**Who might be able to join this trial:** - People who have been diagnosed with cirrhosis (scarring of the liver) from any cause, confirmed by a liver biopsy, imaging scans, clinical signs such as fluid in the abdomen or swollen veins in the food pipe, or a special liver stiffness test - People considered to be at hig...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) that cannot be treated with surgery or ablation (a procedure that destroys cancer cells using heat, cold, or other methods), and where doctors have determined that a systemic (whole-body) treatm...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) that has not spread to other parts of the body - People who have had surgery aimed at completely removing the cancer, and this was the only cancer treatment received - People where no remai...

**Who might be able to join this trial:** - People who are willing and able to give written consent before the surgical procedure begins, with the understanding that leaving the study at any time is allowed - People aged 18 or older - People whose general health and ability to carry out daily activities falls within a...

Who might be able to join this trial: - You have been diagnosed with, or are suspected to have, liver cirrhosis (scarring of the liver), as determined by doctors at the Department of Gastroenterology and Hepatology at Linköping University Hospital — this may be based on different types of tests, scans, or symptoms, and...

**Who might be able to join this trial:** - People who are willing and mentally able to give written consent before any study-related testing begins. - Adults aged 21 to 90 at the time of signing the consent form. - People who are able to attend scheduled visits and follow study procedures. - People diagnosed with hep...

**Who might be able to join this trial:** - Adults between 18 and 65 years old, of any sex - People who have been diagnosed with stage IV hepatobiliary cancer (cancer of the liver, bile ducts, or gallbladder), confirmed by both imaging scans and tissue testing - People for whom palliative (comfort-focused) care is the...

**Who might be able to join this trial:** - People who have signed an informed consent form agreeing to take part in the study - People whose liver cancer has been confirmed through a tissue sample (biopsy) - People whose cancer has spread, cannot be surgically removed, or is considered locally advanced - People who h...

**Who might be able to join this trial:** - People who are willing and able to give their consent to take part in the study - People aged 18 years or older - People who have been diagnosed with small liver cancer (hepatocellular carcinoma, or HCC) that is at an early stage — meaning 1 to 3 tumours each smaller than 3...

**Who might be able to join this trial:** - Adults over 18 years old of any gender - People who are willing and able to give their informed consent to take part in the study - People who have been diagnosed with cirrhosis (scarring of the liver) that is classed as Child-Pugh A or B (a measure of how well the liver is...

**Who might be able to join this trial:** - People of any age who have a suspected or confirmed diagnosis of a rare liver tumour called relapsed/refractory hepatoblastoma (rrHBL), as determined by their treating cancer specialist or surgeon - Children under 6 years of age at the time of their first diagnosis who have...

**Who might be able to join this trial:** - People who are able to give written consent and follow the study requirements. - People who have been confirmed by lab testing (tissue or cell sample) to have extensive-stage small cell lung cancer (ES-SCLC) with liver spread (metastases) found on imaging at diagnosis. - Peo...

Who might be able to join this trial: - Adults aged 18 or older, of any gender - People diagnosed with a type of primary liver cancer called hepatocellular carcinoma (HCC), confirmed either through medical imaging according to Chinese clinical guidelines or through a tissue/cell sample test - People whose liver cancer...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (HCC) that has not spread to the lymph nodes or other parts of the body. - People who have previously had surgery or a radiofrequency ablation procedure to treat their liver cancer, with no signs of the cancer coming back with...

**Who might be able to join this trial:** - People diagnosed with advanced liver cancer (hepatocellular carcinoma, or HCC) at a specific advanced stage, confirmed either by a tissue sample or through clinical assessment - People whose liver cancer has come back after surgery or a procedure to destroy the tumor (ablati...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (liver cancer), confirmed by biopsy, lab testing of cells, or clinical diagnosis by a doctor - People whose liver cancer has stopped responding to a procedure called TACE (a treatment that delivers chemotherapy dir...

**Who might be able to join this trial:** - You are willing to take part and agree to sign a consent form. - You are 18 years of age or older (any gender can apply). - You have been diagnosed with liver cancer (hepatocellular carcinoma), confirmed by a tissue sample, cell sample, or medical imaging. - Your liver cancer...

**Who might be able to join this trial:** - People aged between 40 and 70 years old. - People diagnosed with advanced liver cancer (confirmed by a tissue or cell sample) that cannot be treated with surgery or local treatments, and whose cancer has worsened or who could not tolerate standard treatments. - People whose...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed according to recognised medical guidelines, with liver function falling within a specific accepted range (called Child-Pugh score A or B7). - People who have at least one tumour t...

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with hepatocellular carcinoma (liver cancer) and have recently experienced bleeding from enlarged veins in the esophagus or stomach, where that bleeding was successfully treated within the past 4 weeks using standard procedures such...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), confirmed by tissue or imaging tests - People whose liver cancer tumour tissue tests positive for a protein called GPC3, based on a lab test of a tissue sample taken within the past year (...

Who might be able to join this trial: - People who are over 18 years old at the time of signing the consent form - People who have been confirmed through a tissue biopsy to have stage IV non-small cell lung cancer (a type of lung cancer), or whose stage III lung cancer has come back or spread after treatment with a dru...

**Who might be able to join this trial:** - People who are willing and able to give informed consent and follow the study requirements for the whole duration of the trial. - People who are 18 years of age or older at the time of signing the consent form. - People who have been diagnosed (confirmed by tissue testing) w...

Who might be able to join this trial: - People aged between 21 and 99 years old - People who have been diagnosed with a type of liver cancer called hepatocellular carcinoma (HCC), either confirmed by a tissue sample or by specialised medical scans following established guidelines - People who have not yet received any...

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with hepatocellular carcinoma (liver cancer), confirmed by imaging or tissue biopsy - People whose liver cancer cannot be treated with surgery, a liver transplant, or local treatments aimed directly at the tumour...

Who might be able to join this trial: - People who have been diagnosed with stage I, II, or III colon or rectal cancer (confirmed by a laboratory test on tissue) and have finished standard treatment — including surgery, chemotherapy, and/or radiation — at least 2 months ago. - People aged 18 years or older. - People wh...

**Who might be able to join this trial:** - People aged 18 to 75 years old (inclusive) - People who have been diagnosed with primary or metastatic liver cancer, confirmed by a tissue or cell sample - People whose liver cancer has not responded to standard treatment, or for whom standard treatment is not suitable, or w...

**Who might be able to join this trial:** - The patient must be under 18 years old and have already received a liver transplant. - The patient and/or their parent or legal guardian must be willing and able to sign a consent form agreeing to take part in the study. - The patient and/or their parent or legal guardian mus...

**Who might be able to join this trial:** - You have liver tumors (metastases) that spread from colorectal cancer (a low-grade type), confirmed by biopsy or medical scans, and you are about to start a new cancer treatment - You are 18 years old or older - You have at least one liver tumor that is at least 1 cm wide but...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by tissue or cell testing, where the cancer is at an advanced stage that cannot be removed by surgery and/or has spread to other parts of the body. - People who have at least one...

**Who might be able to join this trial:** - A diagnosis of colorectal cancer (specifically adenocarcinoma) confirmed by tissue testing - Liver metastases (cancer spread to the liver) confirmed by imaging or tissue testing - Liver metastases that a specialist team has determined cannot be surgically removed, based on s...

**Who might be able to join this trial:** - The participant, or their legally authorised representative, must be able to understand the study and be willing to sign a written consent form. - Adults aged 18 years or older of any sex. - People who are generally well enough to carry out normal daily activities with littl...

**Who might be able to join this trial:** - Adults aged 18 or older. - (For liver cancer patients) People with locally advanced, inoperable, returned, or spread liver cancer (hepatocellular carcinoma/HCC), confirmed by biopsy, lab testing, or imaging. - (For liver cancer patients) People whose liver cancer got worse w...

**Who might be able to join this trial:** - People aged between 18 and 75 years. - People diagnosed with hepatocellular carcinoma (a type of liver cancer) according to specific medical guidelines, or confirmed by laboratory tissue or cell testing. - People who have not previously received cancer treatment for this liv...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by a tissue biopsy or lab examination - People whose liver cancer is classified as an early-to-intermediate stage under China's national liver cancer staging guidelines (CNLC stag...

Who might be able to join this trial: - People who are able to provide written consent to participate - Both men and women are eligible - People who weigh more than 50 kg - People who are 18 years of age or older - People who are scheduled to have a complex aortic surgery, liver removal surgery, or pancreatic removal s...

**Who might be able to join this trial:** - You have been diagnosed with liver cancer (hepatocellular carcinoma) that cannot be removed by surgery and has reached an advanced stage - Your liver is functioning at a reasonable level, classified as Child-Pugh A or B (confirm with trial site) - You are generally able to ca...

**Who might be able to join this trial:** - People who have been diagnosed with colorectal cancer that has spread to other parts of the body at the same time as the original diagnosis (known as synchronous metastatic colorectal cancer), and whose treatment is being planned with the goal of curing the cancer at Skåne Un...

Who might be able to join this trial: - You must be 18 years of age or older - You must be well enough to carry out daily activities, either fully or with some limitations (your doctor can confirm if your fitness level qualifies) - You must be able to sign a written consent form agreeing to take part - You must have be...

Who might be able to join this trial: - People who are at least 18 years old - People who are about to begin a type of radiation therapy (using a machine that combines MRI scanning with radiotherapy) for a cancerous tumour that moves with body functions such as breathing — most commonly in the pancreas, liver, kidneys,...

**Who might be able to join this trial:** - People who have given written consent and are willing to take part in all study activities for the full duration of the trial - People who are 18 years of age or older - People whose colorectal cancer has been confirmed by laboratory testing of tissue (biopsy) - People whose...

**Who might be able to join this trial:** - People aged 18 or older - People who have a confirmed advanced solid tumour (diagnosed through a tissue or cell sample) that has stopped responding to standard treatments, or where no standard treatments exist — in some cases, a doctor may enrol a patient who has chosen to d...

**Who might be able to join this trial:** - Adults aged 18 or older, of any race or sex, whose colorectal cancer has spread to the liver, confirmed by biopsy or imaging - People whose cancer has continued to grow or spread after trying two different standard chemotherapy treatments - People who have at least one liver...

**Who might be able to join this trial:** - People aged 18 to 75 years, of any gender - People who have colorectal cancer that has spread to the liver and have had surgery to fully remove the affected tissue (or had a procedure called ablation with a similar result), based on a specialist team review - People whose blo...

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender. - People with a confirmed diagnosis of liver cancer (hepatocellular carcinoma, or HCC), either confirmed by a tissue or cell sample from a laboratory report, or diagnosed by a specialist using recognised clinical guidelines. - People w...

**Who might be able to join this trial:** - People aged 18 to 75 years old, of any gender - People who have been diagnosed with primary liver cancer (hepatocellular carcinoma), confirmed by tissue testing or clinical assessment - People whose liver cancer came back within 3 years after surgery or ablation treatment to...

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with advanced liver cancer (hepatocellular carcinoma, or HCC) and whose medical team has recommended a specific type of immunotherapy (called PD-1 or PD-L1 treatment) as their first treatment - People wh...

**Who might be able to join this trial:** - Adults who have a chronic liver disease and who meet the European liver disease guidelines for regular liver cancer screening. - People who have signed an informed consent form agreeing to take part in the study. **Who may not be able to join:** - People who have previously...

Who might be able to join this trial: - Adults aged 18 or older (male or female) who have been diagnosed with a specific stage of liver cancer (called BCLC Stage B hepatocellular carcinoma) and have been referred for a procedure called TACE - People whose liver tumour measures at least 3 cm across and has been confirme...

Who might be able to join this trial: - Adults aged 18 or older at the time of joining the study - People who have been diagnosed with liver cancer (HCC) confirmed by a laboratory examination of tumor tissue - People who have not previously received any systemic (whole-body) treatment for their liver cancer - People wh...

**Who might be able to join this trial:** - People who are over 18 years of age - People who are in generally good health and able to carry out daily activities (as assessed by their doctor using standard health scales) - People who have a confirmed diagnosis of colorectal cancer based on tissue testing - People who ha...

Who might be able to join this trial: - People aged 18 or older. - People diagnosed with colorectal cancer that has spread only to the liver and cannot be surgically removed. - People whose cancer has not visibly spread outside the liver (though small, stable lung nodules under 6mm may be acceptable — confirm with tria...

**Who might be able to join this trial:** - You have signed and dated a consent form agreeing to take part in the study - You have been diagnosed with hepatocellular carcinoma (a type of liver cancer) - You are 18 years of age or older - You are able to attend scheduled appointments and follow the study requirements -...

**Who might be able to join this trial:** - People who have been newly referred to a specialist with a suspected or confirmed diagnosis of liver cancer (hepatocellular carcinoma, or HCC) - People who are 18 years of age or older **Who may not be able to join:** - People who do not wish to take part in the study - Peop...

**Who might be able to join this trial:** - People who have agreed to take part and have signed a consent form - People aged 18 to 75 years old (male or female) - People who have been clinically or pathologically diagnosed with hepatocellular carcinoma (a type of liver cancer) and have at least one measurable area of...

**Who might be able to join this trial:** - People who have been clinically diagnosed with hepatocellular carcinoma (a type of liver cancer) - People for whom laparoscopic hepatectomy (keyhole surgery to remove part of the liver) has been chosen as the surgical approach, and who agree to take part **Who may not be abl...

**Who might be able to join this trial:** - You are at least 18 years old - You have been diagnosed with liver cancer (HCC) confirmed by a tissue sample or by standard European liver disease guidelines - Your tumor(s) are smaller than 5 cm, and the total of your largest tumor's size (in cm) plus the number of tumors yo...

**Who might be able to join this trial:** - Adults aged 18 or older - People whose ability to carry out daily activities is largely unaffected by their illness (confirm with trial site for exact scoring) - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), either through imaging or...

**Who might be able to join this trial:** - People aged 18 to 75 years old, of any gender - People who are willing to take part and able to sign a consent form - People expected to live for at least 12 weeks - People who are generally well enough to carry out light activity or desk work (a doctor will assess this usin...

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are scheduled to have open liver surgery (removing 3 or more segments of the liver) at the MUMC+ hospital - People who understand Dutch well enough to give consent and follow instructions during the study assessments **Who...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by a tissue sample (biopsy) - People who are of Armenian descent - People who have signed a form agreeing to take part in the trial Who may not be able to join: - People who have not...

**Who might be able to join this trial:** - People who are able to understand and are willing to sign a written consent form to take part in the study. - People who have been diagnosed with fibrolamellar hepatocellular carcinoma (a rare type of liver cancer) or another type of cancer that has spread or cannot be surgi...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on specific liver imaging standards used by liver disease specialists. - People whose general physical functioning is rated at a level indicating they are fully active or have only mi...

Who might be able to join this trial: - People aged 18 years or older. - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) according to recognised international diagnostic guidelines. - People whose liver cancer has been classified as stage C using the Barcelona Clinic Liver Cancer (...

**Who might be able to join this trial:** - Adults between 18 and 75 years old, of any gender - People diagnosed with primary liver cancer (hepatocellular carcinoma) either through standard clinical diagnosis guidelines or confirmed by a tissue or cell sample, with at least one measurable tumour - People who have not...

**Who might be able to join this trial:** - People aged between 18 and 75 years - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), confirmed by imaging, tissue sample, or cell testing - People whose liver cancer has spread into a specific part of a major liver blood vessel, classif...

**Who might be able to join this trial:** - People diagnosed with advanced liver cancer (BCLC Stage C), confirmed either through a tissue sample or by clinical assessment - People whose liver cancer is suitable for a procedure called TACE (a treatment that delivers chemotherapy directly to the liver through blood vess...

**Who might be able to join this trial:** - People who are between 19 and 80 years of age - People whose liver is functioning at a level doctors classify as "Child-Pugh class A" (a measure of liver health — confirm with trial site) - People whose general physical health and ability to carry out daily activities is rate...

**Who might be able to join this trial:** - People diagnosed with liver cancer (hepatocellular carcinoma, or HCC) that cannot be removed by surgery, at a stage classified as BCLC B or C, confirmed by biopsy or clinical assessment - People who have at least one measurable liver tumour that has not yet been treated - Pe...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (liver cancer), confirmed either by a tissue sample or by clinical assessment - People who have not received any previous treatment for their liver cancer - People who have at least one measurable liver tumour that...

Who might be able to join this trial: - You have an advanced solid tumor (a cancer that has spread or cannot be removed) - Your cancer can be measured on scans, following standard measurement guidelines called RECIST v1.1 - You are generally able to carry out daily activities with little or no limitation (confirm with...

**Who might be able to join this trial:** - People aged 18 or older. - People with a new diagnosis of liver cancer (hepatocellular carcinoma) that has not yet been treated, confirmed by tissue sample or imaging, with at least one tumour that can be measured using standard imaging guidelines. A previous liver cancer tr...

Who might be able to join this trial: - Adults aged 18 years or older - People who have been diagnosed with cirrhosis (scarring of the liver), either through clinical assessment or a tissue biopsy - People who do not currently have any active liver complications (such as fluid buildup, bleeding, or confusion related to...

**Who might be able to join this trial:** - People who have been diagnosed with colorectal cancer (specifically adenocarcinoma) that has spread to the liver - People between 18 and 75 years old, of any gender - People who have already received a first course (first-line) of chemotherapy and whose cancer was either red...

Who might be able to join this trial: - You have been diagnosed with colorectal cancer that has spread to the liver and/or the lining of the abdomen (peritoneum) - Your doctors have a plan to perform surgery with the goal of fully removing the cancer Who may not be able to join: - Your colorectal cancer has not spread...

**Who might be able to join this trial:** - People who have been diagnosed with Fibrolamellar Carcinoma (FLC) — a rare type of liver cancer — that has spread to other parts of the body or cannot be removed by surgery. - People whose tumour tissue has tested positive for a specific genetic change called the DNAJB1-PRKA...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC), confirmed by imaging scans, tissue sample, or cell sample. - People who meet specific genetic and/or blood test results — specifically, those with a certain combination of genetic markers (r...

**Who might be able to join this trial:** - People aged 18 to 75 years old - People with a general health status rated as fully active or restricted only in physically strenuous activity (confirm with trial site) - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) at a specific mid-t...

**Who might be able to join this trial:** - You are between 20 and 60 years old - You have been diagnosed with liver cancer (Hepatocellular Carcinoma) classified at a moderate to advanced stage (known as BCLC Stage B or C) - You are able to carry out most normal daily activities, as measured by a standard health scorin...

Who might be able to join this trial: - People who are 18 years of age or older - People who have been assessed by their doctor as suitable for liver surgery to remove part of the liver - People where the portion of liver that would remain after surgery is less than 30% of the normal expected liver size for their body...

**Who might be able to join this trial:** - People who have been diagnosed with intrahepatic cholangiocarcinoma (a type of bile duct cancer that starts inside the liver), confirmed by a tissue or cell sample, and whose cancer appears removable by surgery based on imaging scans. - People whose cancer can be measured on...

Who might be able to join this trial: - You must be 18 years of age or older - Your liver must be functioning at a level rated as "A" or "B" on a standard liver health scoring system (called Child-Pugh classification) - You have a long-term (chronic) liver disease and have been identified as being at high risk of devel...

Who might be able to join this trial: - People who have been clinically diagnosed with hepatocellular carcinoma (a type of liver cancer). - People aged between 18 and 75 years. - People whose largest tumor measures at least 10 cm, and whose total tumor size is at least 15 cm. - People with intermediate to advanced larg...

**Who might be able to join this trial:** - People who are willing and able to sign a written consent form agreeing to take part in the trial - People who are 15 years of age or older at the time of signing the consent form - People who have been diagnosed with metastatic adrenocortical carcinoma (ACC) that has spread...

**Who might be able to join this trial:** - People who have solid tumour cancers that have spread, cannot be surgically removed, or are at an advanced stage, and whose cancer has stopped responding to at least one standard chemotherapy or targeted therapy treatment. - People whose cancer can be accessed for a biopsy (...

**Who might be able to join this trial:** - You must be willing to take part and sign a consent form after being fully informed about the study - You must be between 18 and 70 years old - You must have advanced liver cancer that has been confirmed by a tissue sample (biopsy) - You must be generally well enough to carr...

Who might be able to join this trial: - A diagnosis of liver cancer (hepatocellular carcinoma) confirmed by tissue sample or by meeting recognised medical diagnostic guidelines for this type of cancer. - Adults aged 18 or older. - Fully active and able to carry out normal daily activities without any restriction (a spe...

Who might be able to join this trial: - You are over 18 years old - You have breast cancer that has spread to the liver (confirm with trial site for exact definition) - You have breast cancer that has spread to the liver and also to other parts of the body outside the liver - You have received any type of treatment (th...

**Who might be able to join this trial:** - People who have been confirmed by tissue testing to have a type of bile duct cancer that started inside the liver (called intrahepatic cholangiocarcinoma, or iCCA) - People who have been newly diagnosed with this type of cancer for the first time - People whose cancer came b...

Who might be able to join this trial: - You have been diagnosed with liver cancer (hepatocellular carcinoma) that has spread or cannot be removed by surgery, confirmed by a biopsy, lab test, or by standard medical guidelines if you also have liver scarring (cirrhosis). - Your liver cancer is classified as Stage B or C...

**Who might be able to join this trial:** - People who have been diagnosed with perihilar cholangiocarcinoma (a type of bile duct cancer near the liver), confirmed through specific tests such as tissue sampling, a blood marker test, or imaging scans showing a blockage that looks cancerous - People whose cancer cannot...

Who might be able to join this trial: - You must be over 18 years old - You are being considered for a major surgery to remove part of the liver - You have bowel (colorectal) cancer that has spread to the liver, and that spread can be removed with surgery Who may not be able to join: - You are not able to give your co...

**Who might be able to join this trial:** - You are 18 years of age or older - You have been diagnosed with colorectal cancer that has spread to the liver, confirmed by a biopsy and seen on imaging scans - You are reasonably active and able to carry out daily activities (confirm with trial site for specific fitness le...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma/HCC) that doctors have determined cannot be treated with surgery or a liver transplant, with tumours meeting specific size limits (no single tumour larger than 15 cm, and the total size of all tumours...

Who might be able to join this trial: - People who are 18 years of age or older at the time of signing the consent form - People who have a confirmed diagnosis of locally advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer that starts inside the liver), based on tissue testing - People whose cancer has...

**Who might be able to join this trial:** - Adults between 18 and 75 years old (male or female) - People whose liver cancer has been identified through pre-surgery scans as an early to intermediate stage (BCLC stage 0, A, or B) and is considered suitable for surgery to remove the cancer completely - People with a good...

Who might be able to join this trial: - Adults aged 18 or older - People diagnosed with liver cancer (hepatocellular carcinoma) that is located in only one lobe of the liver, confirmed by tissue sample and/or imaging scans - People who have at least one liver tumour larger than 10 mm that can be measured on a specialis...

Who might be able to join this trial: - People aged 18 to 75, of any gender - People who have been diagnosed with primary liver cancer (hepatocellular carcinoma) that is classified as BCLC stage C (an advanced stage) - People whose liver function is rated as Child-Pugh Grade A or B (these are measures of how well the l...

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by tissue sample and/or medical imaging - People who have no more than five liver tumours on imaging scans, where the largest tumour is bigger than 8 cm - People w...

Who might be able to join this trial: - People aged 18 years or older - People whose case has been reviewed by a team of medical specialists (a multidisciplinary tumour board) who have recommended a liver treatment procedure that uses heat or cold to destroy tumour tissue through the skin - People who are willing and a...

**Who might be able to join this trial:** - You have been diagnosed with liver cancer (hepatocellular carcinoma) at a specific stage range, need a procedure called TACE (where medicine is delivered directly to the tumor through blood vessels), and are not able to have or have chosen not to have surgery, a liver transp...

**Who might be able to join this trial:** - People aged 18 or older. - People with liver metastases (cancer that has spread to the liver) who have been recommended for surgery to remove those metastases by a specialist medical team. - People who have given written consent to participate in the study. - People who have...

Who might be able to join this trial: - People aged between 18 and 80 years old. - People who have both bowel cancer (colorectal cancer) and liver metastases (cancer that has spread to the liver) present at the time of assessment. - People whose primary bowel tumour, located in the colon or upper part of the rectum, ca...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on specific international guidelines used by liver disease specialists. - People who have at least one tumor that can be clearly measured using established liver cancer assessment met...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma). - People who are planned to have surgery to remove part of the liver (hepatectomy). - People whose liver is functioning at a healthy enough level, classified as Child-Pugh A (confirm with trial site). -...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (liver cancer) through laboratory testing of tissue removed during surgery, where the surgical margin (the border between the tumour and the healthy tissue removed around it) was less than 1 centimetre wide - Peopl...

**Who might be able to join this trial:** - You are 18 years of age or older. - You have been diagnosed with colorectal cancer (a specific type called adenocarcinoma), confirmed by a tissue sample test. - Scans have shown that the cancer has spread to the liver only, with no confirmed spread to other parts of the body...

Who might be able to join this trial: - People who have been diagnosed with colorectal cancer that has spread to the liver (known as colorectal liver metastases) - People who have had surgery, with tissue samples taken and examined in a laboratory to confirm their diagnosis - People who have no medical reasons preventi...

**Who might be able to join this trial:** - People who have been diagnosed with decompensated liver cirrhosis (a serious stage of liver scarring where the liver is no longer able to function properly). - Adults aged 18 or older. - Healthy adults aged 18 or older (who would take part as a comparison group). **Who may n...

**Who might be able to join this trial:** - Adults aged over 18 and up to 75 years old, of any gender, who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC) either confirmed by tissue testing or by meeting recognised medical diagnostic guidelines. - People whose liver cancer is classified as BCL...

**Who might be able to join this trial:** - You are 18 years old or older - You are on the waiting list for a liver transplant in France for liver cancer (hepatocellular carcinoma, or HCC), or you are currently being assessed for a transplant under French health authority (Agence de Biomédecine) rules - Your liver can...

**Who might be able to join this trial:** - People aged 18 to 75 years old who have liver cancer or other liver tumours and are scheduled for a keyhole (laparoscopic) liver removal surgery that targets a specific section of the liver - People whose liver is functioning at a level rated as Grade A or B on a standard me...

Who might be able to join this trial: - You are 18 years of age or older. - You have been diagnosed with liver cancer (hepatocellular carcinoma), either confirmed by a tissue sample (biopsy) or by medical imaging scans. - Your doctor has assessed that you may benefit from a treatment plan that includes immunotherapy co...

Who might be able to join this trial: - People who have signed a written consent form before any trial-related procedures begin - People whose physical functioning is rated at 0 or 1 on a standard medical scale (meaning fully active or able to carry out light activities) - People who have been confirmed, through tissue...

**Who might be able to join this trial:** - People aged 18 to 75 years - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by tissue testing, at an early stage (classified as BCLC stage 0 or A) - People whose cancer has not spread outside the liver - People who showed no si...

Who might be able to join this trial: - Adults aged 18 or older - People who have tested positive for the hepatitis B surface antigen (a marker of hepatitis B infection) for at least six months - People who are citizens of the Republic of Türkiye Who may not be able to join: - There are no exclusion criteria listed fo...

**Who might be able to join this trial:** - People aged 18 to 75 years old (any gender) - People who are willing to take part and are able to sign a consent form on their own - People diagnosed with advanced liver cancer (hepatocellular carcinoma) confirmed by a tissue or cell sample, at a specific advanced stage, who...

**Who might be able to join this trial:** - Adults aged 18 to 90 years who received a liver transplant more than 6 months ago - People who have been diagnosed with liver cancer (HCC) that has come back after their transplant, based on specific recognised diagnostic guidelines - People whose liver cancer has come back...

**Who might be able to join this trial:** - People who are older than 18 years of age - Both men and women are eligible - People who have tumours that started in the liver or spread to the liver from elsewhere - People whose cancer is mainly located in the liver - People who have at least one tumour measuring more tha...

**Who might be able to join this trial:** - Patients who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) and are already enrolled in, or eligible for, a specific liver disease registry at the trial site - Adults aged 18 or older who have been diagnosed with this type of liver cancer, confirm...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma), either confirmed by a tissue biopsy or by standard liver disease diagnostic guidelines - People who have cancer that has spread to lymph nodes in the abdomen, confirmed by CT or MRI scan, where the total...

**Who might be able to join this trial:** - People who are scheduled to receive TACE (a procedure that delivers treatment directly to a liver tumour) for a liver tumour - People who are at least 18 years old - People who are in a stable medical condition - Women of childbearing age who have a negative pregnancy test re...

**Who might be able to join this trial:** - People who have signed a written consent form before enrolling - People aged over 18 years old, of any sex - People who have been diagnosed with intermediate or advanced liver cancer (hepatocellular carcinoma), confirmed by tissue or pathology testing, or people with liver s...

**Who might be able to join this trial:** - Adults between 18 and 75 years of age (inclusive). - People who have not previously received systemic cancer treatment, or who meet the criteria for spleen removal during treatment. - People diagnosed with liver cancer (hepatocellular carcinoma) that cannot be surgically rem...

Who might be able to join this trial: - Adults aged 18 to 75 years old - People who have been diagnosed with colorectal cancer (a type of bowel cancer) confirmed through laboratory testing of tissue samples - People whose cancer has spread to the liver, with no more than 5 spots (lesions) in the liver, confirmed by sca...

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with colorectal cancer that has spread to the liver, as confirmed by a specialist medical team - People whose liver metastases (cancer spread to the liver) appeared either at the same time as or after the origina...

**Who might be able to join this trial:** - People aged 18 or older at the time of signing the consent form - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), confirmed either by a tissue sample or by standard clinical criteria in people with liver scarring (cirrhosis) - People wh...

**Who might be able to join this trial:** - People who have been diagnosed with colorectal cancer that has spread (metastasized) to the liver - People who are planning to have surgery to remove their liver metastases - People whose tumor has tested negative for a specific genetic marker called MSI-H/dMMR (confirm with...

Who might be able to join this trial: - People between 18 and 70 years old (any gender). - People who have been newly diagnosed with pancreatic cancer that has spread to the liver, confirmed by a tissue sample (biopsy) or medical assessment, and has not spread to any other organs. - People whose tumours can be seen on...

**Who might be able to join this trial:** - People who are willing to take part voluntarily, understand the study procedures, and sign a consent form - Adults aged 18 to 75 years, of any gender - People who have been diagnosed with an advanced solid tumour (confirmed by laboratory testing of tissue or cells) whose can...

**Who might be able to join this trial:** - People aged 18 or older who are willing to sign a consent form and follow the study requirements. - People with a confirmed diagnosis of liver cancer (hepatocellular carcinoma, or HCC), either through a tissue sample or by standard clinical criteria. - People whose liver can...

**Who might be able to join this trial:** - People who have been confirmed to have liver cancer that has spread (metastatic), either through a tissue biopsy or through specific patterns seen on a CT scan or MRI, and for whom surgery is not an option - People who are generally able to carry out daily activities with li...

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have not previously received any local or systemic treatment for liver cancer (hepatocellular carcinoma) - Your liver function is within an acceptable range, based on a scoring system called Child-Pugh (score of 7 or below) - You are...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma), either confirmed by a tissue sample or by established medical diagnosis guidelines - People who have liver cancer that has come back or is still present after previous treatment, with no spread to b...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by a tissue sample, by standard liver cancer diagnostic guidelines, or as a recurrence after surgery - People between 18 and 75 years of age - People whose liver cancer is classif...

**Who might be able to join this trial:** - Adults aged 19 years or older (male or female) - People who have been diagnosed with advanced liver cancer (hepatocellular carcinoma) confirmed by imaging, tissue sample, or fluid sample, whose cancer has continued to grow despite standard treatments, or who cannot tolerate...

**Who might be able to join this trial:** - People who are able to start a targeted therapy treatment within 1–2 months after receiving a liver transplant. - People whose anti-rejection medication plan includes three specific drugs: a calcineurin inhibitor, mycophenolate mofetil, and sirolimus. - People who are willin...

**Who might be able to join this trial:** - You have been diagnosed with a specific type of liver cancer (called infiltrative hepatocellular carcinoma, or HCC) confirmed by MRI or CT scan - Your liver is functioning reasonably well, rated as Child-Pugh class A or B (confirm with trial site), and you are generally able...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC) that has been assessed as not suitable for surgery or a liver transplant, with one or more tumours where no single tumour is larger than 15 cm and the total size of all tumours combined is less th...

Who might be able to join this trial: - Adults between 18 and 80 years old - People rated as generally healthy to moderately unwell before surgery, based on a standard medical fitness scale (ASA Class I–III) - People who are scheduled for a planned (non-emergency) liver removal surgery Who may not be able to join: - P...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of primary liver cancer) confirmed by a tissue sample analysis - People who have been diagnosed with intrahepatic cholangiocarcinoma (a type of bile duct cancer that starts inside the liver) confirmed by a tissu...

Who might be able to join this trial: - People who have had a colonoscopy at the same time as their blood sample was taken for the study - People who have gone through the standard tests and procedures used in their area to diagnose and determine the stage of their condition, and who had at least one blood sample taken...

**Who might be able to join this trial:** - Adults who are already scheduled as part of their regular medical care to have ultrasound or MRI scans to monitor for liver cancer (HCC), or to have an MRI scan to get a closer look at a nodule (small growth) found on the liver. **Who may not be able to join:** - People who...

**Who might be able to join this trial:** - People who have given written consent and are able to attend scheduled visits and follow study procedures - People aged 18 to 75 years, of any gender - People diagnosed with liver cancer (hepatocellular carcinoma, or HCC) according to Chinese national guidelines or confirmed...

Who might be able to join this trial: - People who are willing to take part in clinical research, who fully understand the study, and who are able to sign a consent form and complete all required procedures - People who are 18 years of age or older at the time of signing the consent form - People who have been diagnose...

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have been diagnosed with liver cancer linked to viral hepatitis or cirrhosis, confirmed through scans (such as CT or MRI) or a tissue sample/biopsy, following specific medical guidelines - Your liver function has been rated as reason...

Who might be able to join this trial: - People who have a primary cancer in the upper abdomen (such as pancreatic cancer, bile duct cancer, or liver cancer), or cancer that has spread to the upper abdomen (including the liver, adrenal glands, or nearby lymph nodes), and who are scheduled to receive a type of targeted r...

**Who might be able to join this trial:** - People whose general health and ability to carry out daily activities falls within a certain functional range (rated 0–2 on a standard medical scale) - People who have been diagnosed with colorectal cancer that has spread to the liver, confirmed by laboratory testing of tiss...

**Who might be able to join this trial:** - People diagnosed with liver cancer (hepatocellular carcinoma) that has spread to nearby tissues or other parts of the body, or cannot be removed by surgery - People who have not previously received any systemic (whole-body) drug treatment for their liver cancer. Prior use of...

Who might be able to join this trial: - People who have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by a tissue or cell sample, or whose liver cancer has been diagnosed by clinical criteria set by a major liver disease association (AASLD). - People aged 18 to 75 years old. - People who have a...

**Who might be able to join this trial:** - You are willing to participate, agree to follow-up visits, and have signed a written consent form - You are between 18 and 80 years old (any gender) - You have been officially diagnosed with hepatocellular carcinoma (a type of liver cancer) and have had a tissue sample (biop...

**Who might be able to join this trial:** - You have been diagnosed with liver cancer (hepatocellular carcinoma), either confirmed by a tissue sample or based on established medical guidelines - Your cancer has not spread to other parts of the body - Surgery, liver transplant, or ablation treatment are not suitable opt...

**Who might be able to join this trial:** - People aged 18 to 75 years old (inclusive). - People who have been diagnosed with advanced liver cancer (hepatocellular carcinoma) that cannot be removed by surgery or has spread, confirmed by tissue sample, cell sample, or imaging, and whose cancer has not responded to stan...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), including those with more than one tumour — confirmed either by a tissue or cell sample test, or by specific patterns seen on a CT or MRI scan - People aged 18 or older at the time of sign...

Who might be able to join this trial: - People who have recently received their first-ever diagnosis of hepatocellular carcinoma (a type of primary liver cancer). - People with this type of liver cancer who are planned to have surgery, whether or not they are also receiving treatment beforehand to shrink the cancer. -...

**Who might be able to join this trial:** - People who are willing to take part and who, or whose legal representative, can sign a consent form agreeing to participate - Adults aged 18 or older, of any gender - People who have been newly diagnosed with liver cancer (hepatocellular carcinoma), either with strong clinica...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma) that also involves a blood clot in the portal vein or hepatic vein - People aged between 18 and 90 years old - People whose liver measurements meet specific volume and radiation dose thresholds set b...

**Who might be able to join this trial:** - People diagnosed with liver cancer (hepatocellular carcinoma) that cannot be removed by surgery, at a moderate or advanced stage, confirmed either by a biopsy or by clinical assessment - People who have at least one measurable liver tumor that has not yet been treated - Peop...

**Who might be able to join this trial:** - People who have been diagnosed with hepatocellular carcinoma (liver cancer), either confirmed by a tissue sample or diagnosed by their doctor using clinical methods. - People who have at least one measurable liver tumour that can be tracked during the trial. - People whose l...

Who might be able to join this trial: - People who have liver tumors and have been assessed by a hospital's specialist liver tumor team as being suitable for minimally invasive (keyhole) surgery - People who have had a contrast-enhanced MRI scan of the liver within 6 weeks before their planned liver surgery - People wh...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), either confirmed by a tissue sample or by clinical assessment. - People who received certain treatments before surgery as their first treatment, such as chemotherapy delivered directly to the l...

**Who might be able to join this trial:** - People who have signed a written consent form before taking part in the trial - People who have been confirmed to have hepatocellular carcinoma (a type of liver cancer) through a tissue or cell sample, or who meet established medical diagnostic guidelines for this condition...

Who might be able to join this trial: - People aged 18 years or older who are undergoing a liver transplant where the donor liver is kept viable using a special cooling and oxygen machine process (called hypothermic oxygenated machine perfusion). Who may not be able to join: - People who are pregnant. - People receivi...

**Who might be able to join this trial:** - Adults aged 18 years or older, of any gender - People who have a confirmed diagnosis of hepatocellular carcinoma (liver cancer), confirmed using recognised medical guidelines - People whose liver cancer cannot be removed by surgery - People whose liver cancer has gotten wors...

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have not previously received any treatment (local or systemic) for liver cancer - Your liver function is at an acceptable level, based on a scoring system called Child-Pugh (score of 7 or below — confirm with trial site) - You are abl...

**Who might be able to join this trial:** - You have liver function that is rated as "A" or "B" on a standard medical scale (called Child-Pugh Class A or B), meaning your liver is still functioning reasonably well. - You have a suspected liver cancer (either primary liver cancer or cancer that has spread to the liver f...

Who might be able to join this trial: - People who have been diagnosed with primary liver cancer (hepatocellular carcinoma) or a different type of liver cancer that is not hepatocellular carcinoma. - People who are able to read, understand, and sign a consent form, or who have a legal representative who can do this on...

Who might be able to join this trial: - Adults aged 18 or older - People who are generally well enough to carry out daily activities with little or no limitation (as measured by a standard medical scale called ECOG, scoring 0 or 1) - People who have a confirmed diagnosis of hepatocellular carcinoma (a type of liver can...

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with liver cancer (hepatocellular carcinoma) that cannot be removed by surgery, has spread locally, or has spread to other parts of the body — with the diagnosis confirmed by biopsy, cell testing, or specific med...

**Who might be able to join this trial:** - Adults between 18 and 80 years of age. - People who are willing to participate, have signed a consent form, and are able to attend follow-up appointments. - People whose primary colorectal cancer (bowel cancer) can be fully removed by surgery, and where the diagnosis has bee...

**Who might be able to join this trial:** - People who are willing to take part voluntarily and sign a consent form. - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) either through a tissue/cell sample test or according to recognised clinical guidelines (2024 Edition). - People w...

**Who might be able to join this trial:** - People aged 18 to 70 years, of any gender - People who have voluntarily agreed to take part and signed a consent form (either themselves or through a guardian) - People with liver cancer (HCC) that cannot be surgically removed, classified as stage B or C under a system calle...

**Who might be able to join this trial:** - You have been newly diagnosed with liver cancer (hepatocellular carcinoma) and have not yet received any treatment for it - Your tumor is considered larger than usual guidelines allow for standard treatment — either one tumor larger than 5 cm, or 2–3 tumors where the largest...

Who might be able to join this trial: - You have recently been diagnosed with a type of liver cancer called hepatocellular carcinoma (HCC), confirmed by imaging scans and/or a tissue sample, following standard diagnostic guidelines - You have had a specific type of abdominal scan (a three-phase contrast-enhanced CT sca...

**Who might be able to join this trial:** - A laboratory test (tissue or cell sample) must have confirmed a cancer diagnosis. - Participants must be 18 years or older and have an estimated life expectancy of more than 3 months. - Liver function must fall within a specific range, measured by a scoring system called Chi...

**Who might be able to join this trial:** - People aged 18 to 75 years of any gender - People who are willing and able to give written consent to participate - People who have a confirmed diagnosis of liver cancer (hepatocellular carcinoma), confirmed by imaging, tissue sample, or cell sample - People who are willing...

**Who might be able to join this trial:** - People aged 18 to 75 years old - People whose general health and ability to carry out daily activities falls within an acceptable range for this trial (confirm with trial site) - People who have been diagnosed with advanced liver cancer (hepatocellular carcinoma) that cannot...

**Who might be able to join this trial:** - A laboratory test (tissue or cell sample) has confirmed a cancer diagnosis. - The person is willing and able to sign a consent form before joining the trial. - The person is aged 18 or older and is expected to live for more than 3 months. - Liver function falls within an acc...

Who might be able to join this trial: - People who are 22 years of age or older - People who have signed the ethics committee or review board approved consent form before any study-related tests or procedures, and who are willing to follow the study procedures and required check-ups - People whose liver tumor or tumors...

**Who might be able to join this trial:** - You have liver cancer (hepatocellular carcinoma, or HCC) that has spread to nearby tissues, other parts of the body, or cannot be removed with surgery - Your liver is still functioning reasonably well (a measure called Child-Pugh A — confirm with trial site) - Your liver can...

**Who might be able to join this trial:** - People who have a confirmed diagnosis of hepatocellular carcinoma (a type of liver cancer), confirmed either through a tissue sample or through standard clinical assessment - People who are willing and able to sign a consent form agreeing to take part in the trial - People w...

**Who might be able to join this trial:** - People who are women, or men whose liver adenoma has been determined to be non-removable by surgery regardless of its size - People who are willing to provide written consent to take part in the study - People who have a liver adenoma (hepatocellular adenoma) confirmed by ti...

**Who might be able to join this trial:** - People who have a confirmed diagnosis of hepatocellular carcinoma (liver cancer) - People whose largest liver tumour is bigger than 7 cm - People whose scans show a blood clot or tumour growth in the main vein supplying the liver (called portal vein tumour thrombus) - People...

**Who might be able to join this trial:** - People who have been diagnosed with liver cancer (hepatocellular carcinoma) that has been confirmed by a tissue or cell sample, and who have not yet received any treatment for it. A biopsy before treatment starts may not be needed if one has already been done, but diagnosis...

Who might be able to join this trial: - People aged 18 to 80 years old, of any gender. - People who are willing to take part voluntarily, have signed a consent form, and are able to attend follow-up appointments. - People who have been diagnosed with primary liver cancer (hepatocellular carcinoma) confirmed by tissue t...

**Who might be able to join this trial:** - Your colorectal cancer spread to the liver (liver metastases) and was surgically removed with the goal of curing you, but you could not receive a specific chemotherapy drug called oxaliplatin before or around the time of surgery, either for medical reasons or because you cou...

**Who might be able to join this trial:** - You are willing to read and sign a consent form agreeing to take part in the study. - You are between 18 and 75 years old. - You have a specific genetic marker called HLA-A 02:03 (this would be confirmed through a blood test). - You have been diagnosed with liver cancer (hep...

**Who might be able to join this trial:** - People who are admitted to hospital or attending as an outpatient with advanced chronic liver disease, diagnosed based on a standard set of medical guidelines called the BAVENO criteria **Who may not be able to join:** - People who are pregnant - People who are under 18 year...

Who might be able to join this trial: - People between 18 and 70 years of age - People who have had a liver examination performed before an ultrasound-guided liver biopsy or surgery - People whose liver tumor can be seen clearly on a standard ultrasound scan - People whose largest tumor image has been saved in a specif...

**Who might be able to join this trial:** - People diagnosed with liver cancer (hepatocellular carcinoma/HCC) confirmed either by biopsy or by CT or MRI scan, at a stage where the cancer is either advanced (BCLC stage C) or at an intermediate stage (BCLC stage B) where local treatments are not suitable - People who ha...

**Who might be able to join this trial:** - You are 18 years of age or older at the time of signing the consent form. - You have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC), confirmed either by imaging scans using standard criteria or by a tissue biopsy. - Your treatment plan includes a procedu...

**Who might be able to join this trial:** - People who are willing and able to give written consent to participate. - People who have a life expectancy of at least 3 months. - People who are generally well enough to carry out daily activities with little or no limitation (as measured by a standard medical scale called...

Who might be able to join this trial: - People who have had curative treatment (surgery or local ablation) for liver cancer (HCC) and have had no recurrence for more than two years after that treatment - People who have never received systemic treatment, radiation therapy, or a procedure called trans-arterial chemoembo...

Who might be able to join this trial: - People diagnosed with advanced liver cancer (hepatocellular carcinoma) Who may not be able to join: - People who have serious ongoing health conditions such as severe diabetes, heart failure, or liver and/or kidney failure - People who have a history of schizophrenia - People wh...

**Who might be able to join this trial:** - People who are willing to give their voluntary written consent to participate - People aged 18 years or older but under 75 years old, of any gender - People who have been diagnosed with, or are suspected of having, liver cancer for the first time within the past 42 days befo...

**Who might be able to join this trial:** - You have been diagnosed with colorectal cancer confirmed by a laboratory test (biopsy or tissue sample) - You are generally able to carry out normal daily activities with little or no restriction (confirm with trial site) - Your tumor has been tested and shown to have a speci...

**Who might be able to join this trial:** - People who have been diagnosed with primary (first-occurring) liver cancer (HCC), confirmed by biopsy or by standard clinical guidelines - People whose liver cancer has spread to a small number of sites (called oligometastasis), with the spread detected within three months o...

**Who might be able to join this trial:** - You are a man or woman aged 18 or older - You have been diagnosed with liver cancer (hepatocellular carcinoma, or HCC), confirmed by a biopsy or scan using recognised medical guidelines - Your liver cancer has spread, cannot be surgically removed, or is considered advanced,...

**Who might be able to join this trial:** - People who have colorectal cancer that has spread to the liver, where the cancer cannot be fully removed by surgery or is on the borderline of being removable. - People who have not yet received chemotherapy for their metastatic (spread) disease. - People who are reasonably w...

**Who might be able to join this trial:** - People who have been diagnosed with colorectal cancer (a type of bowel cancer) that has been confirmed by a tissue sample analysis, specifically the type called adenocarcinoma. - People whose cancer has spread to the liver and cannot be removed by surgery, with the liver bei...

Who might be able to join this trial: - People who fully understand the study and are willing to sign a consent form agreeing to take part. - People aged between 18 and 75 years old. - People who are rated as largely able to carry out daily activities with little to no limitation, based on a standard medical assessment...

Who might be able to join this trial: - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on tissue testing, classified according to World Health Organization standards. - People whose first planned treatment is surgery aimed at fully removing the liver cancer (curative-intent...

**Who might be able to join this trial:** - People who are willing to take part and able to sign a consent form agreeing to join the study - People aged between 18 and 75 years old, of any gender - People whose liver is functioning at a level that doctors classify as "Child-Pugh class A" (a measure of how well the liv...

**Who might be able to join this trial:** - Women between 18 and 75 years of age - People who have been diagnosed through a tissue/cell test (pathology) with breast cancer that has spread to the liver, and who are unable to have surgery or have chosen not to have surgery - People who have no more than 3 liver tumours,...

**Who might be able to join this trial:** - People who are willing to take part voluntarily and have signed a consent form. - People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) either through a tissue/cell test or through clinical guidelines. - People who have already received immuno...

**Who might be able to join this trial:** - People who had surgery to fully remove a liver cancer tumour within the 4 weeks before being enrolled in the trial - People whose tumour characteristics show a high risk that the cancer could come back - People who did not receive any cancer treatment before surgery, except...

**Who might be able to join this trial:** - People who voluntarily agree to take part and sign a consent form (or have a legal guardian sign on their behalf) - People aged 18 to 75 years old at the time of signing the consent form - People who have been confirmed by tissue or cell testing to have advanced liver cancer...